I think this would mean short term pain for financials and wait/hope for investors that management would be able to execute all these strategies. I think management is spreading itself too thin too fast. More so considering limited bench strength and management bandwidth as of now. So biggest risk is focused business delivering great return can easily become de-focused low return business.

Till Q2 Concall, sales were around 38 cr + orders worth 46 cr was expected to be dispatched by Mgmt for Q3 & Q4 = 84 cr for FY 17. Mgmt mentioned that they would repeat performance of 38 cr in second half i.e 76 cr but were not committing to entire 84 cr for FY17. Reported Net Sales were 82.93 cr, so essentially Co. fell short by 1.07 cr, which is not much and also something that I`m not entirely sure of.

I do not remember mention of renewal order in present concall. Last time mgmt said SA tender is expected to be in Dec`17 & that they might increase their requirements by 50% more than previous tender. Another trigger that I forgot to mention above, Thanks!

As per Q4 con call...it is 125 cr where cupid is L1 in first half. Larger GOI and international tenders will follow in second Half of the FY18. Request to go through con call as it gives detailed guidance.

A female condom (also known as a femidom or internal condom) is a device that is used during sexual intercourse as a barrier contraceptive to reduce the risk of sexually transmitted infections (STIs—such as gonorrhea, syphilis, and HIV, though its protection against them is inferior to that by male condoms) and unintended pregnancy. Invented by Danish MD Lasse Hessel, it is worn internally by the female partner and provides a physical barrier to prevent exposure to ejaculated semen or other bo Th...

Interesting to note at the various attempts ( both ongoing & abandoned) for the FDA clinical trials from various competitors.

Logically and scientifically, it is the male condom mkt which shd grow- it is much better than female condom in all respects! Only in parts of Africa and with prostitutes etc it is the female condom which has some mkt. How many of investors in Cupid use female condom instead of male?As world becomes more literate and educated, the need of female condoms may not be there!

Hello SirI have some points1. FC is a high margin business2. It is under penetrated 3. FC business has less competition4. If FC gets USFDA nod than co can sell fc for 2 dollars each. 5. There are already various players in MC , which makes margin less which ultimately reduces EBIDTA.

It is worth noting that management projected contribution from Lubes to jump from 5% last year to 10% this FY.. Considering 15 to 20 percent growth for this FY this would be a more than 100% growth for this new product line.

Yes, agree. FC has EBITDA margin of 50-55% currently, but competition will catch up in 1-5 years. FC margins can dip to 30%. Also, there is a real issue of succession. The promoter is in his 70s and his children not keen to run the business. Cupid is looking out for a professional CEO. Also, he wants to move away form B2B to B2C gradually which requires huge investments in brand building and is very competitive.